Medicare Enrolled

Dr. Ho-Kan Cheng, M.D.

Pulmonary Disease · Woodbury, NJ
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
52 W RED BANK AVE, Woodbury, NJ 08096
8568532025
Registered in NPPES since 2005
NPI: 1881692374 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cheng from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cheng? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Cheng

Dr. Ho-Kan Cheng is a pulmonary disease specialist in Woodbury, NJ, with 21 years of NPI registration. Based on federal Medicare data, Dr. Cheng performed 1,253 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Cheng received a total of $5,446 from 32 pharmaceutical and/or device companies across 357 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Cheng is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years of NPI registration ▲ 1,253 Medicare services $5,446 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,253
Medicare services
Bottom 45% in NJ for pulmonary disease
Not available
Unique patients (not deduplicated)
$95
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
447 $67 $151
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
349 $101 $218
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
147 $143 $421
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
78 $103 $281
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
54 $181 $607
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
35 $96 $281
Chest fluid aspiration with imaging guidance
This procedure involves removing fluid from the chest cavity using imaging technology to guide the needle placement.
30 $92 $235
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
29 $65 $199
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
19 $152 $395
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
18 $24 $75
Bronchial secretion aspiration via endoscope
Removal of initial lung airway secretions using an endoscope. This procedure involves inserting a scope into the airways to clear fluid or mucus.
16 $116 $314
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
16 $51 $135
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
15 $52 $199
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,446
Total received (2018-2024)
Avg $778/year across 7 years
Top 27% in NJ for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
357
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$626
2023
$178
2022
$98
2021
$119
2020
$378
2019
$2,457
2018
$1,589

Payments by company (2024)

GlaxoSmithKline, LLC.
$271
GENZYME CORPORATION
$165
JAZZ PHARMACEUTICALS INC.
$66
Regeneron Healthcare Solutions, Inc.
$25
Philips North America LLC
$20
Resmed Corp
$18
AstraZeneca Pharmaceuticals LP
$16
Axsome Therapeutics, Inc.
$16
United Therapeutics Corporation
$15
Mylan Specialty L.P.
$14
Top 3 companies account for 80.2% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,160
AstraZeneca Pharmaceuticals LP
$791
Olympus Corporation of the Americas
$406
GENZYME CORPORATION
$353
Boehringer Ingelheim Pharmaceuticals, Inc.
$330
Genentech USA, Inc.
$296
Philips Electronics North America Corporation
$165
Janssen Pharmaceuticals, Inc
$161
JAZZ PHARMACEUTICALS INC.
$151
Novartis Pharmaceuticals Corporation
$144
Regeneron Healthcare Solutions, Inc.
$138
Electromed, Inc.
$128
Actelion Pharmaceuticals US, Inc.
$125
Mylan Specialty L.P.
$122
Sunovion Pharmaceuticals Inc.
$120
Inspire Medical Systems, Inc.
$119
Jazz Pharmaceuticals Inc.
$118
Grifols USA, LLC
$86
Circassia Pharmaceuticals Inc
$72
PFIZER INC.
$60
United Therapeutics Corporation
$58
Shire North American Group Inc
$56
Insmed, Inc.
$52
Bayer HealthCare Pharmaceuticals Inc.
$41
Resmed Corp
$35
Axsome Therapeutics, Inc.
$32
Teva Pharmaceuticals USA, Inc.
$29
Harmony Biosciences LLC
$29
Vapotherm Inc
$24
Philips North America LLC
$20
Merck Sharp & Dohme Corporation
$13
ADVANCED RESPIRATORY, INC
$11
Top 3 companies account for 43.3% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · AIRSENSE · ANORO · ANORO ELLIPTA · AREXVY · ASMANEX · Adempas · Arikayce · Astral · BREO · BREZTRI · BROVANA · CHANTIX · CINQAIR · DUAKLIR PRESSAIR · DUPIXENT · Dymista · ELIQUIS · Esbriet · FASENRA · GLASSIA · Inspire Upper Airway Stimulation System · LONHALA MAGNAIR · NIOX VERO · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · Olympus EBUS Bronchoscopes · Prolastin-C · Prolastin-C Liquid · Respiratoriy Care Undiv · SMARTVEST · SPIRIVA · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · Utibron · VAPOTHERM · Wakix · Wellcentive Undiv · XARELTO · XOLAIR · XYREM · XYWAV · Xolair · Xyrem · YUPELRI · Yupelri · inCourage
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a pulmonary disease specialist in Woodbury?
Compare pulmonary diseases in the Woodbury area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases in nearby ZIP areas
262
County median income
$102,807
Nearest hospital to ZIP centroid (approximate)
NORTHBROOK BEHAVIORAL HEALTH HOSPITAL
5.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Cheng is a mixed practice specialist, with moderate Medicare volume, with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Cheng experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Cheng performed 447 hospital follow-up visit, moderate complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Cheng receive payments from pharmaceutical companies?
Yes. Dr. Cheng received a total of $5,446 from 32 companies across 357 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cheng's costs compare to other pulmonary diseases in Woodbury?
Dr. Cheng's average Medicare payment per service is $95. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cheng) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →